FX-55 has an interesting history. The parent developer FX-50 was designed as two concentrates A and B. The theory was that keeping the ascorbic acid away from the alkaline chemicals in the developer would improve shelf life. However the problem, as with Xtol, was not aerial oxidation but rather with Fenton oxidation. After the commercial failure of FX-50 Crawley again tried to improve the keeping qualities of the developer. He did so with FX-55 where the ascorbic acid is added at the last minute before use. A useful but not commercially viable solution. Of course we now know that the Fenton reaction can be prevented with the addition of a suitable chelating agent to the developer formula. While FX-55 appears to be a competent developer there is the problem of having to lug out the scales each time one wants to develop film.